MAPT and Alzheimer disease: Neuronal cholesterol elimination via 24-HC affects amyloid precursor protein processing and is associated with brain atrophy and gray matter loss, with CSF levels correlating with AD markers such as Aβ, tau, and phospho-tau [331].